Current Psychopharmacology
Volume 10, 3 Issues, 2021
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Abstracts Ahead of Print
There are currently no Abstracts Ahead of Print available for this journal.
Editor-in-Chief
Kenneth Blum
Western University of Health Sciences
Pomona, CA
(USA)
Biography
Western University of Health Sciences
Pomona, CA
Biography
Biography of Kenneth Blum
Dr. Blum serves as Chairman of Geneus Sciences LLC., His concept of Reward Deficiency Syndrome is
being embraced by world leaders in science and is part of the DSM –V, ASAM, Sage Encyclopedia of abnormal and clinical psychology 2017. Dr, Blum is credited with the DRD2 gene discovery and addictive diseases. He
serves as Editor-in-Chief in Journal of Reward Deficiency Syndrome (he coined) and Addiction Sciences
and Co-EIC of Journal of Neuroimaging in Psychiatry and Neurology (USG). He is currently serving on
fourteen other prestigious journal’s Editorial Boards. He has published over 450 articles, 16 books,
numerous patents and received many awards (Life-Time Achievements) for his seminal discoveries. He is
the founding President of United Scientific Group (USG).
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Psychopharmacology was launched in 2012. Dr. Kenneth Blum serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net